Cargando…
High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
Metastatic colorectal cancer is a leading cause of cancer death. However, current therapy options are limited to chemotherapy, with the addition of anti-EGFR antibodies for patients with RAS wild-type tumours. Novel drug targets, or drug combinations that induce a synergistic response, would be of g...
Autores principales: | Williams, Steven P., Barthorpe, Andrew S., Lightfoot, Howard, Garnett, Mathew J., McDermott, Ultan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625556/ https://www.ncbi.nlm.nih.gov/pubmed/28972570 http://dx.doi.org/10.1038/sdata.2017.139 |
Ejemplares similares
-
Corrigendum: High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
por: Williams, Steven P., et al.
Publicado: (2018) -
Systematic high-content genome-wide RNAi screens of endothelial cell migration and morphology
por: Williams, Steven P., et al.
Publicado: (2017) -
Genome-wide RNAi screen for synthetic lethal interactions with the C. elegans kinesin-5 homolog BMK-1
por: Maia, André F., et al.
Publicado: (2015) -
A genome-scale RNAi screen for genetic interactors of the dynein co-factor nud-2 in Caenorhabditis elegans
por: Rocha, Helder, et al.
Publicado: (2018) -
RNAi screens for Rho GTPase regulators of cell shape and YAP/TAZ localisation in triple negative breast cancer
por: Pascual-Vargas, Patricia, et al.
Publicado: (2017)